Viewing Study NCT05291156


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-01-01 @ 7:57 AM
Study NCT ID: NCT05291156
Status: RECRUITING
Last Update Posted: 2024-02-01
First Post: 2022-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy
Sponsor: University of Campania Luigi Vanvitelli
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module